I E Eder - JoVE Visualize

Showing results (11-20 of 18) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 18 results.

The Prostate|October 12, 2000

Expression of androgen receptor coregulatory proteins in prostate cancer and stromal-cell culture modelsC Nessler-Menardi, I Jotova, Z Culig, et al.

Cancer Research|January 19, 1999

Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell linesT Putz, Z Culig, I E Eder, et al.

Cancer Gene Therapy|August 5, 2000

Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotidesI E Eder, Z Culig, R Ramoner, et al.

European Urology|May 15, 1999

Mechanism of androgen receptor activation and possible implications for chemoprevention trialsH Klocker, Z Culig, I E Eder, et al.

The American Journal of Pathology|December 14, 1999

Basic fibroblast growth factor synthesis by human peritoneal mesothelial cells: induction by interleukin-1M V Cronauer, S Stadlmann, H Klocker, et al.

British Journal of Cancer|September 25, 1999

Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model systemZ Culig, J Hoffmann, M Erdel, et al.

British Journal of Cancer|October 29, 1998

Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cellsZ Culig, A Hobisch, M Herold, et al.

The Prostate|June 1, 1997

Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostateM V Cronauer, A Hittmair, I E Eder, et al.

Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 18 results.

The Prostate|October 12, 2000

Expression of androgen receptor coregulatory proteins in prostate cancer and stromal-cell culture modelsC Nessler-Menardi, I Jotova, Z Culig, et al.

Cancer Research|January 19, 1999

Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell linesT Putz, Z Culig, I E Eder, et al.

Cancer Gene Therapy|August 5, 2000

Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotidesI E Eder, Z Culig, R Ramoner, et al.

European Urology|May 15, 1999

Mechanism of androgen receptor activation and possible implications for chemoprevention trialsH Klocker, Z Culig, I E Eder, et al.

The American Journal of Pathology|December 14, 1999

Basic fibroblast growth factor synthesis by human peritoneal mesothelial cells: induction by interleukin-1M V Cronauer, S Stadlmann, H Klocker, et al.

British Journal of Cancer|September 25, 1999

Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model systemZ Culig, J Hoffmann, M Erdel, et al.

British Journal of Cancer|October 29, 1998

Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cellsZ Culig, A Hobisch, M Herold, et al.

The Prostate|June 1, 1997

Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostateM V Cronauer, A Hittmair, I E Eder, et al.

Pageof 2